HHS Fundamental Analysis - HARTE-HANKS INC

Fundamental Rating

Overall HHS gets a fundamental rating of 3 out of 10. We evaluated HHS against 100 industry peers in the Media industry. While HHS seems to be doing ok healthwise, there are quite some concerns on its profitability. HHS has a valuation in line with the averages, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

HHS had negative earnings in the past year.

In the past year HHS has reported a negative cash flow from operations.

The reported net income has been mixed in the past 5 years: HHS reported negative net income in multiple years.

The reported operating cash flow has been mixed in the past 5 years: HHS reported negative operating cash flow in multiple years.

1.2 Ratios

HHS has a Return On Assets of -3.18%. This is comparable to the rest of the industry: HHS outperforms 48.00% of its industry peers.

HHS has a Return On Equity of -13.57%. This is comparable to the rest of the industry: HHS outperforms 45.00% of its industry peers.

The Return On Invested Capital of HHS (6.95%) is better than 74.00% of its industry peers.

HHS had an Average Return On Invested Capital over the past 3 years of 11.42%. This is above the industry average of 8.87%.

The 3 year average ROIC (11.42%) for HHS is well above the current ROIC(6.95%). The reason for the recent decline needs to be investigated.

		Industry Rank	Sector Rank
ROA	-3.18%
ROE	-13.57%
ROIC	6.95%

ROA(3y)-0.52%

ROA(5y)1.66%

ROE(3y)13.57%

ROE(5y)N/A

ROIC(3y)11.42%

ROIC(5y)N/A

1.3 Margins

The Operating Margin of HHS (3.21%) is comparable to the rest of the industry.

HHS's Operating Margin has declined in the last couple of years.

HHS's Gross Margin of 18.54% is on the low side compared to the rest of the industry. HHS is outperformed by 74.00% of its industry peers.

HHS's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	3.21%
PM (TTM)	N/A
GM	18.54%

OM growth 3Y-16.84%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.08%

GM growth 5Y15.62%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HHS is creating some value.

HHS has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, HHS has more shares outstanding

The debt/assets ratio for HHS is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 14.49 indicates that HHS is not in any danger for bankruptcy at the moment.

HHS has a Altman-Z score of 14.49. This is amongst the best in the industry. HHS outperforms 95.00% of its industry peers.

A Debt/Equity ratio of 0.02 indicates that HHS is not too dependend on debt financing.

With an excellent Debt to Equity ratio value of 0.02, HHS belongs to the best of the industry, outperforming 82.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Altman-Z	14.49

ROIC/WACC0.8

WACC8.71%

2.3 Liquidity

A Current Ratio of 1.60 indicates that HHS should not have too much problems paying its short term obligations.

Looking at the Current ratio, with a value of 1.60, HHS is in the better half of the industry, outperforming 66.00% of the companies in the same industry.

A Quick Ratio of 1.60 indicates that HHS should not have too much problems paying its short term obligations.

The Quick ratio of HHS (1.60) is better than 66.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.6
Quick Ratio	1.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.87%, which is quite impressive.

Looking at the last year, HHS shows a decrease in Revenue. The Revenue has decreased by -6.48% in the last year.

The Revenue has been decreasing by -3.17% on average over the past years.

EPS 1Y (TTM)89.87%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-103.55%

Revenue 1Y (TTM)-6.48%

Revenue growth 3Y-1.63%

Revenue growth 5Y-3.17%

Sales Q2Q%-14.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y131.2%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year4.05%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HHS. In the last year negative earnings were reported.

Based on the Price/Forward Earnings ratio of 3.58, the valuation of HHS can be described as very cheap.

HHS's Price/Forward Earnings ratio is rather cheap when compared to the industry. HHS is cheaper than 97.00% of the companies in the same industry.

When comparing the Price/Forward Earnings ratio of HHS to the average of the S&P500 Index (22.87), we can say HHS is valued rather cheaply.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	3.58

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HHS is valued cheaper than 97.00% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	2.35

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

HHS does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HARTE-HANKS INC

NASDAQ:HHS (9/23/2025, 1:57:13 PM)

3.87

+0.13 (+3.48%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)08-07 2025-08-07/amc

Earnings (Next)11-12 2025-11-12

Inst Owners31.9%

Inst Owner Change-2.5%

Ins Owners38.44%

Ins Owner Change1.8%

Market Cap28.68M

Analysts80

Price TargetN/A

Short Float %0.39%

Short Ratio1.26

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	3.58
P/S	0.16
P/FCF	N/A
P/OCF	N/A
P/B	1.29
P/tB	1.34
EV/EBITDA	2.35

EPS(TTM)-0.41

EYN/A

EPS(NY)1.08

Fwd EY27.93%

FCF(TTM)-1

FCFYN/A

OCF(TTM)-0.62

OCFYN/A

SpS23.61

BVpS3

TBVpS2.9

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.18%
ROE	-13.57%
ROCE	8.8%
ROIC	6.95%
ROICexc	7.51%
ROICexgc	7.61%
OM	3.21%
PM (TTM)	N/A
GM	18.54%
FCFM	N/A

ROA(3y)-0.52%

ROA(5y)1.66%

ROE(3y)13.57%

ROE(5y)N/A

ROIC(3y)11.42%

ROIC(5y)N/A

ROICexc(3y)13.82%

ROICexc(5y)N/A

ROICexgc(3y)14.26%

ROICexgc(5y)N/A

ROCE(3y)14.46%

ROCE(5y)N/A

ROICexcg growth 3Y-19.31%

ROICexcg growth 5YN/A

ROICexc growth 3Y-19.72%

ROICexc growth 5YN/A

OM growth 3Y-16.84%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.08%

GM growth 5Y15.62%

F-Score4

Asset Turnover1.84

Health

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Debt/EBITDA	0.05
Cap/Depr	64.48%
Cap/Sales	1.64%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.6
Quick Ratio	1.6
Altman-Z	14.49

F-Score4

WACC8.71%

ROIC/WACC0.8

Cap/Depr(3y)122.2%

Cap/Depr(5y)111.4%

Cap/Sales(3y)2.1%

Cap/Sales(5y)1.87%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)89.87%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-103.55%

EPS Next Y131.2%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-6.48%

Revenue growth 3Y-1.63%

Revenue growth 5Y-3.17%

Sales Q2Q%-14.22%

Revenue Next Year4.05%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-39.85%

EBIT growth 3Y-18.2%

EBIT growth 5YN/A

EBIT Next Year198.68%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-137.18%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-119.45%

OCF growth 3YN/A

OCF growth 5YN/A

HARTE-HANKS INC (HHS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens